The Falling Walls Foundation has awarded Prof. Dr. Marcus Mall of Charité—Universitätsmedizin Berlin the title Science Breakthrough of the Year 2022 in Life Sciences for a new treatment approach to ...
Cystic fibrosis remains an incurable genetic disorder which impairs lung function and significantly reduces life expectancy. A new combination drug therapy which addresses the disorder's underlying ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
The development of gene editing tools, which enable the specific targeting and correction of mutations, hold the promise of allowing us to correct those mutations that cause genetic diseases. However, ...
Alfredo has a PhD in Astrophysics and a Master's in Quantum Fields and Fundamental Forces from Imperial College London.View full profile Alfredo has a PhD in Astrophysics and a Master's in Quantum ...
Infants from minoritized racial and ethnic backgrounds who have positive newborn screening tests for cystic fibrosis received their diagnostic follow-up for the disease later than recommended and ...
WASHINGTON (Reuters) - U.S. scientists have created pigs that appear to develop cystic fibrosis just as people do, a step they hope will accelerate efforts to tackle the disease. Writing in the ...
Two nationally recognized experts in cloning and stem cell science from the University of Houston are taking the first step toward limiting the consequences of chronic inflammation in cystic fibrosis ...
One of this year's coveted Lasker Awards went to three scientists who helped invent a life-saving treatment for cystic fibrosis, a genetic disease. When you purchase through links on our site, we may ...
Cystic Fibrosis Diagnosis: Top Testing Methods Explained: By Shimona Patel Cystic Fibrosis is a complex genetic disorder that requires careful evaluation to confirm its presence. Defined by issues in ...
The triple-drug combination Trikafta has given a new lease of life to 90% of people with cystic fibrosis, an inherited disorder that affects the lungs and other organs. Now, the trio of researchers ...